Come up with a name for your new list and we'll add to it:
Abreos Biosciences raised a round of funding on June 28, 2016. Investors include
Vertical Venture Partners.
Abreos Biosciences develops lateral flow assays that measure the activity of high value biologics. The company's simple devices can be used for quality assurance, pharmacokinetic monitoring, and authe…